Amryt Pharma Past Performance

How has Amryt Pharma performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


25.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: AMYT has a large one-off gain of $52.9M impacting its June 30 2022 financial results.

Growing Profit Margin: AMYT became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: AMYT has become profitable over the past 5 years, growing earnings by 25.9% per year.

Accelerating Growth: AMYT has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: AMYT has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (5%).


Return on Equity

High ROE: AMYT's Return on Equity (0.8%) is considered low.


Discover strong past performing companies